ActiGraft
Commercial- Indications
- Chronic wounds, Diabetic ulcers, Neuropathic ulcers, Venous ulcers, Pressure injuries
Company intelligence / Profile preview
RedDress
Ponte Vedra Beach / Jacksonville*, Florida, United Statesreddress.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company’s lead product ActiGraft Pro has demonstrated significant clinical efficacy in randomized controlled trials for chronic neuropathic foot ulcers. Patients treated with ActiGraft Pro were more than twice as likely to heal compared to standard of care. Since FDA clearance and CE Mark in 2020, the product has been used on nearly 7,000 patients across the US and over thirty countries.
- Therapeutic areas
- OtherDermatologyCardiovascular
- Modalities
- DeviceAutologous blood-derived therapy (classified as "Device" and "Biologic" in some regulatory contexts)Regenerative medicine technology
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on RedDress.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RedDress.